Showing 2901-2910 of 5621 results for "".
- AMA Unveils New Policy Framework to Combat AI “Deepfake” Impersonation of Physicianshttps://modernod.com/news/ama-unveils-new-policy-framework-to-combat-ai-deepfake-impersonation-of-physicians/2487044/Key Takeaways The AMA has introduced a new policy framework aimed at protecting
- International Congress of Scleral Contacts: A Chance to Advance Your Skillshttps://modernod.com/news/international-congress-of-scleral-contacts-a-chance-to-advance-your-skills/2486922/Given that scleral contact lenses can manage corneal conditions, such as keratoconus, and treat dry eye disease effectively, it makes sense for ODs to be aware of the latest related innovations to continue to meet these patients’ vision and comfort needs. This is where the International Congress
- Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Dealhttps://modernod.com/news/sun-pharma-to-acquire-organon-in-1175-billion-all-cash-deal/2486921/Key Takeaways
- World Council of Optometry and Alcon Video Series Summarizes TFOS DEWS IIIhttps://modernod.com/news/world-council-of-optometry-and-alcon-video-series-summarizes-tfos-dews-iii/2486845/World Council of Optometry (WCO) and Alcon have released a series of three videos to help eye care professionals (ECPs) around the world understand and apply recommendations from the r
- Haag-Streit USA, Marco Lombart Sign Exclusive US Distribution Deal for Diagnostic Platformshttps://modernod.com/news/haag-streit-usa-marco-lombart-sign-exclusive-us-distribution-deal-for-diagnostic-platforms/2486763/Haag-Streit USA and Marco Lombart have entered into an exclusive distribution agreement for the Lenstar 900 optical biometer and the Octopus 600 and Octopus 900 perimeters in the United States. Under the agreement, Marco Lomb
- Revenio Group to Acquire Visionix in 290 Million Euro Dealhttps://modernod.com/news/revenio-group-to-acquire-visionix-in-290-million-euro-deal/2486649/Revenio Group has signed an agreement to acquire the entire share capital of France-based LT International SAS, the parent company of the Visionix International group, in a transaction valued at €290 million ($342 million). T
- EyeMed Vision Care, Vision Council Foundation Expand Partnership for Second Yearhttps://modernod.com/news/eyemed-vision-care-vision-council-foundation-expand-partnership-for-second-year/2486331/Key Takeaways
- China Approves World’s First Implantable Device for Congenital Nystagmus Treatmenthttps://modernod.com/news/china-approves-worlds-first-implantable-device-for-congenital-nystagmus-treatment/2486098/
- BostonSight Announces Leadership Changes to Advance Ocular Surface Care Worldwidehttps://modernod.com/news/bostonsight-announces-leadership-changes-to-advance-ocular-surface-care-worldwide/2485722/BostonSight announced a 5-year strategic roadmap designed to redefine ocular surface treatment through advancements in clinical research, professional education, and specialty lens technology. As part of the plan, BostonSight announced a new leadership structure ai
- HOYA Presents New Data on MiYOSMART iQ Spectacle Lenseshttps://modernod.com/news/hoya-presents-new-data-on-miyosmart-iq-spectacle-lenses/2485625/HOYA Vision Care recently announced interim 6-month data from its randomized controlled clinical trial evaluating the safety and efficacy of MiYOSMART iQ spectacle lenses to treat children 4 to 12 years of age who have progressive myopia. The company’s myopia control solution uses the defocu